Get more info

Get more information
on LUCENTIS:
1-866-LUCENTIS
(1-866-582-3684)

Monday-Friday
8AM-9PM (EST)

 

You'll receive helpful tips & tools, a free information kit, and much more.

Sign Up Now
   

Interested in LUCENTIS?

Print out this page, answer the questions, and bring it to your next doctor appointment to find out if LUCENTIS® (ranibizumab injection) is right for you.

1. Do you have dry AMD or wet AMD?
I have dry AMD       I have wet AMD

2. If you have wet AMD, do you have it in 1 eye or both eyes?
1 eye       Both eyes

3. Please describe what other medical conditions you have and what medications you take for them.





4. Are you being treated for wet AMD? If so, please
note the treatments you have tried, how many treatments you have had, and why you stopped using them.

TREATMENT HOW MANY TREATMENTS STOPPED BECAUSE
Visudyne® (verteporfin for injection) PDT*    
Hot laser    
Macugen® (pegaptanib sodium injection)    
Other injection
___________
   
Alternative therapy
___________
   

Note: Be sure to discuss your complete medical history with your eye doctor.

LUCENTIS
is for prescription use only.
Individual results with LUCENTIS may vary.

*Visudyne is a registered trademark of Novartis Pharmaceuticals Corporation.

Macugen is a registered trademark of (OSI) Eyetech, Inc., and Pfizer Inc.








Who is LUCENTIS for?


LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).


Important LUCENTIS Safety Information


Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.


Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.


Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.


Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.


The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.


LUCENTIS is for prescription use only.

Individual results with LUCENTIS may vary.


Please see LUCENTIS full Prescribing Information.